Verana Health has an expansive real-world data network of more than 20,000 healthcare providers and a comprehensive view of more than 15 diseases affecting more than 90 million patients. We deliver near real-time insights, helping commercial teams go beyond claims data to better understand real-world performance. Our data is curated and analyzed from more than 500 million patient encounters stored in electronic health records (EHRs) to help to paint a full picture of a drug or device's usage and efficacy.
Find out how Verana Health can help guide forecasting, monitor market uptake, track market share, understand drug utilization, and guide label modifications to help inform your commercial strategy.
Use real-world Qdata® to track market share of products across select clinical indications or patient cohorts. We can help you measure sales activity by territory and help forecast future sales performance.
Activate our exclusive Qdata to help understand the competitive landscape and how your therapeutic is performing in the market in comparison to others. We can help you understand the clinical intent behind the treatment choice as captured in the unstructured physician's notes to inform your commercial strategy.
Leverage Qdata to understand usage, particularly off-label usage, of your therapy to inform your strategy around label changes or a new indication. We can help you refine your label expansion approach by delivering quality insights around efficacy and outcomes within select patient cohorts.
Detect drug utilization patterns including initial prescribing, medication changes and patient outcomes. Verana Health’s EHR+ consists of de-identified EHR data combined with de-identified claims data, to deliver unique, high quality insights. These insights include not only the medication change, but can also indicate reasons for medication switching and patient outcomes as captured in unstructured physician notes.
Verana Health helps Marketing professionals leverage real-world data to gain quality insights on real-world performance to guide messaging and targeting strategies. We help you generate evidence to inform your product positioning in the current market.
Verana Health collaborates with Sales teams to help measure sales activity by territory, often in near real-time. Our exclusive insights include de-identified patient and aggregated physician and practice data to guide your sales strategy.
Verana Health supports Commercial Operations teams by delivering insights to guide sales strategy, territory alignment and help forecast future sales performance. We can help you track performance and monitor market share.
One of Verana Health’s clients selected us to build a dashboard powered by de-identified Qdata to track the market share of multiple products across five speciality indications. The dashboard enables the client to track changes in drug uptake shared across clinical indications, forecast future sales, measure sales activity by territory, and more.
Talk to a Qdata Expert
One of Verana Health’s clients wanted to understand real-world utilization of their recently approved drug to compare against their competitors. Using exclusive de-identified EHR data combined with de-identified claims data, we were able to deliver a time-trend analysis of adverse events (AEs) and track the type of patients who are receiving their drug in the real-world, monitor utilization across segments of diseases, and measure real-world patient outcomes.
Talk to a Qdata Expert
One of Verana Health’s clients leveraged our exclusive, de-identified Qdata to monitor post-approval safety and commercial uptake of a marketed product. The client performed pre-and post-launch studies on drug safety and analysis to understand the demographic characteristics of early patients who received the drug. This enabled them to investigate real-world treatment patterns of patients receiving the drug across various cohorts.
Talk to a Qdata Expert
Life Sciences Companies are Customers
Providers Participate in our RWD Network
De-identified Patients Included in our RWD Network
Peer-reviewed Studies Published Using Verana Health Data
Therapeutic Areas with Numerous Diseases
Years Longitudinal Data
*Data Current To: September 2022
We partner with the American Academy of Ophthalmology and manage its IRIS® Registry (Intelligent Research in Sight) with more than 17,000 participating providers.
We partner with the American Urological Association and manage its AQUA Registry with more than 2,100 participating providers.
We partner with the American Academy of Neurology and manage its Axon Registry® with more than 1,400 participating providers.
Exclusive real-world data network of more than 20,000 healthcare providers in ophthalmology, urology, and neurology.
Clinician-directed and AI-enhanced population health data engine powering an advanced data integrity feedback loop.
Research-ready, disease-specific data modules to power quality insights for real-world evidence and clinical trial activation.
Advanced, clinically driven Artificial Intelligence techniques infused throughout the data process across both structured and unstructured data.
Keep up with the latest news about Verana Commercialization
Find out for yourself how Verana Health’s Qdata and quality insights can help you understand drug utilization or monitor your sales activity. Fill out the information below and our team will follow up with you as soon as possible.
Your message has been received. We'll reply to you as soon as possible.